Squarepoint Ops LLC

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in EWTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$229,762

-$991,214 QoQ

Shares Held

5,655

-92.5% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#160

of 223 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. EWTX ranks #199 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$229,762	5,655	-92.5%	Shares	Defined	2026-08-14
2025-09-30	$1,220,976	75,276	+64.5%	Shares	Defined	2025-11-14
2025-03-31	$1,006,632	45,756	+73.6%	Shares	Defined	2025-08-27
2024-12-31	$703,758	26,358	+58.5%	Shares	Defined	2025-02-14
2024-09-30	$443,828	16,629	-68.4%	Shares	Defined	2024-11-14
2024-06-30	$946,263	52,541	+111.4%	Shares	Defined	2024-08-14
2024-03-31	$453,336	24,854	+114.1%	Shares	Defined	2024-05-15
2023-12-31	$127,013	11,610	-4.8%	Shares	Defined	2024-02-14
2021-12-31	$186,370	12,197	-39.6%	Shares	Defined	2022-02-14
2021-03-31	$656,012	20,185	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.